DR. (MRS.) ANILA DWIVEDI
 
  Senior Principal Scientist
Endocrinology Division
Central Drug Research Institute
Lucknow-226 031
 
Educational Qualifications M.Sc., Ph.D.
Date of Birth 31st December, 1959
Telephone 050522-2772450, Extn: 2486 (O)
E-Mailtd> [email protected],[email protected]
 
RESEARCH EXPERIENCE
 
25 years experience in the area of ‘Reproductive Biology and Endocrinology’ including ‘Development of selective estrogen receptor modulators as anti-implantation agents / anticancer agents’
 
CURRENT AREAS OF INTEREST

Molecular Endocrinology
Female Reproduction, Reproductive Disorders, and Endocrine-Related Cancer

RESEARCH GROUP
Ruchi Saxena -Research Fellow
Vishal Chandra- Research Fellow
Iram Fatima- Research Fellow
Murli Manohar- Research fellow
Arti Verma-  Research Fellow- CSMMU collaboration
Mrs Shakti Kitchlu- Sr Tech. Officer
Ph. D. STUDENTS MENTORED

Awarded-6
Ongoing-4

RESEARCH FUNDING

Council of Scientific & Industrial Research,
Ministry of Health & family Welfare,
Indian Council of Medical Research

INTER INSTITUTIONAL COLLABORATIVE PROJECTS

With CSM Medical University, Lucknow  - Two

SELECTED PUBLICATIONS
 
V.Chandra; I. Fatima; R. Saxena, S.Kitchlu, S.Sharma; M.K.Hussain; K.Hajela; P. Bajpai; and A. Dwivedi. Apoptosis induction and inhibition of hyperplasia formation by 2-[piperidinoethoxyphenyl]-3-[4-hydroxyphenyl]-2H-benzo(b)pyran in rat uterus. American Journal of Obstetrics & Gynecology 2011 (In Press)
G. Kharkwal, I. Fatima,S. Kitchlu, B. Singh, K. Hajela and A. DwivediAnti-implantation effect of 2-[piperidinoethoxyphenyl]-3-[4-hydroxyphenyl]-2H benzo(b)pyran, a potent antiestrogenic agent  in rats. Fertility & Sterility 95, 1322-7 (2011)
R. Saxena and A. Dwivedi.ErbB family receptor inhibitors as therapeutic agents in breast cancer: Current status and future clinical perspective.Medicinal Research Reviews, 25 Oct 2010 (In press)
S. Kumar, S. Deshpande, V. Chandra, S. Kitchlu, A. Dwivedi, V.L.Nayak , R. Konwar, Y. S. Prabhakar, D.P. Sahu.Synthesis and biological evaluation of 2, 3, 4-triarylbenzopyran derivatives as SERM and therapeutic agent for breast cancer. Bioorg Med. Chem.17, 6832-40 (2009)
A Daverey, R Saxena, S.Tewari, SK Goel, A. Dwivedi Expression of estrogen receptor co-regulators SRC-1, RIP140 and NCoR and their interaction with estrogen receptor in rat uterus, under the influence of ormeloxifene J Steroid Biochem.Mol. Biol. 116,93-101 (2009)
KR Srinivasan, CS Blesson, I. Fatima, S Kitchlu, PK Mehrotra, SK Jain and A. Dwivedi. Expression of avb3 Integrin in Rat Endometrial Epithelial Cells and its Functional Role During Implantation. Gen. Comp. Endocrinol 160: 124-133 (2009)

S. Awasthi, A. Daverey and A. Dwivedi. Modulation of AP-1 mediated  estrogenic response by ormeloxifene in rat uterus. J. Steroid Biochemistry & Molecular Biology 104, 208-214,(2007)

S. Awasthi, C.S. Blesson and A. Dwivedi . Expression of estrogen receptors a  and b during the period of uterine receptivity in rat: effect of ormeloxifene, a selective estrogen receptor modulator. Acta Physiologica, 47, 47-56 (2007)

C. S. Blesson, S. Awasthi, G. Kharkwal, A. Daverey and A. Dwivedi. Modulation of estrogen receptor transactivation induced by ormeloxifene – A triphenylethylene derivative.Steroids 71, 993-1000 (2006)

K.R. Srinivasan, A. Dwivedi, S.K. Jain and P.K. Mehrotra.Demonstration of uterine receptivity in-vitro by co-culture of rat epithelial cells and blastocyst. Cell and Tissue Research 325, 135-141 (2006)